Evaluation of the Efficacy and Tolerance of a Light Therapy Mask on Mild to Moderate Brown Spots and Moderate to Severe Facial Wrinkles

Sponsor
Johnson & Johnson Consumer Inc. (J&JCI) (Industry)
Overall Status
Completed
CT.gov ID
NCT03312543
Collaborator
(none)
124
1
2
5.9
21.1

Study Details

Study Description

Brief Summary

This research study will test how well a light therapy mask works for women with mild to moderate hyperpigmentation (brown spots) and moderate to severe facial wrinkles, as compared to a "sham" or inactive investigational light therapy mask. The study will also test if the light therapy mask causes any irritation. For the first 12 weeks of the study, participants will use the assigned mask, along with a provided cleanser and sunscreen. For the second 12 weeks of the study, participants will use just the cleanser and sunscreen.

Condition or Disease Intervention/Treatment Phase
  • Device: Active Mask
  • Device: Sham Mask
N/A

Detailed Description

Exposure to sunlight and artificial light sources containing ultraviolet (UV) radiation is known to accelerate the skin's aging process, resulting in unwanted wrinkles, irregular skin tone, and loss of elasticity. Ablative techniques, such as dermabrasion, deep chemical peels, and ablative laser resurfacing of various wavelengths, are well documented to alleviate the signs of photodamage. However, such techniques often require significant post-treatment care and have higher risk profiles than other treatments, with potential side effects including erythema, pigmentation issues, infection, and possible scarring. They may be poorly tolerated by patients who dislike the discomfort, wound care, and prolonged downtime involved.

Non-ablative skin rejuvenation procedures are also effective for improving the appearance of photodamaged skin and are becoming increasingly popular because of their minimal downtime and increased safety. These procedures include intense pulsed light systems, non-ablative lasers, and monochromatic light boxes, which can target facial rhytids, irregular pigmentation, telangiectasia, and skin laxity. Unfortunately, such techniques can be expensive and their use is primarily limited to clinical settings.

However, the light-emitting diode (LED) is a novel light source that is well-suited for non-ablative phototherapy that can be utilized at home for a relatively low price. This study will evaluate the efficacy and tolerance of an LED-based light therapy mask as compared to a sham mask in subjects seeking anti-aging benefits.

Study Design

Study Type:
Interventional
Actual Enrollment :
124 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomized, Evaluator-Blinded Clinical Study to Evaluate the Efficacy and Tolerability of an Investigational Light Therapy Mask on Subjects With Mild to Moderate Mottled Hyperpigmentation and Moderate to Severe Facial Wrinkles
Actual Study Start Date :
Oct 9, 2017
Actual Primary Completion Date :
Jan 12, 2018
Actual Study Completion Date :
Apr 6, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active Cell: Active Mask

Cleanser, Moisturizer, Active Mask

Device: Active Mask
A facial cleanser will be used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF will be applied full-face. For the first 12 weeks of the study, the active light therapy mask will be used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage will be discontinued.
Other Names:
  • Active Light Therapy Mask
  • Sham Comparator: Sham Cell: Sham Mask

    Cleanser, Moisturizer, Sham Mask

    Device: Sham Mask
    A facial cleanser will be used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF will be applied full-face. For the first 12 weeks of the study, the sham light therapy mask will be used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage will be discontinued.
    Other Names:
  • Sham Light Therapy Mask
  • Outcome Measures

    Primary Outcome Measures

    1. Global Wrinkling - Change From Baseline to Week 12, Averaged Expert Grader Scores [Baseline to Week 12]

      3 Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.

    2. Global Wrinkling - Change From Baseline to Week 12, Individual Expert Grader Scores - Expert Grader 1 [Baseline to Week 12]

      Each Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement. Scores for Expert Grader 1 were calculated individually.

    3. Global Wrinkling - Change From Baseline to Week 12, Individual Expert Grader Scores - Expert Grader 2 [Baseline to Week 12]

      Each Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement. Scores for Expert Grader 2 were calculated individually.

    4. Global Wrinkling - Change From Baseline to Week 12, Individual Expert Grader Scores - Expert Grader 3 [Baseline to Week 12]

      Each Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement. Scores for Expert Grader 3 were calculated individually.

    Secondary Outcome Measures

    1. Global Wrinkling - Change From Baseline to Week 1 [Baseline to Week 1]

      3 Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.

    2. Global Wrinkling - Change From Baseline to Week 4 [Baseline to Week 4]

      3 Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.

    3. Global Wrinkling - Change From Baseline to Week 24 [Baseline to Week 24]

      3 Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.

    4. Fine Lines - Change From Baseline to Week 1 [1 week]

      3 Expert Graders evaluated fine lines on a 1-9 scale, where 1 = mildest fine lines to 9 = most severe fine lines. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.

    5. Fine Lines - Change From Baseline to Week 4 [Baseline to Week 4]

      3 Expert Graders evaluated fine lines on a 1-9 scale, where 1 = mildest fine lines to 9 = most severe fine lines. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.

    6. Fine Lines - Change From Baseline to Week 12 [Baseline to Week 12]

      3 Expert Graders evaluated fine lines on a 1-9 scale, where 1 = mildest fine lines to 9 = most severe fine lines. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.

    7. Fine Lines - Change From Baseline to Week 24 [Baseline to Week 24]

      3 Expert Graders evaluated fine lines on a 1-9 scale, where 1 = mildest fine lines to 9 = most severe fine lines. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.

    8. Periorbital Wrinkles - Change From Baseline to Week 1 [Baseline to Week 1]

      3 Expert Graders evaluated periorbital wrinkles on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.

    9. Periorbital Wrinkles - Change From Baseline to Week 4 [Baseline to Week 4]

      3 Expert Graders evaluated periorbital wrinkles on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.

    10. Periorbital Wrinkles - Change From Baseline to Week 12 [Baseline to Week 12]

      3 Expert Graders evaluated periorbital wrinkles on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.

    11. Periorbital Wrinkles - Change From Baseline to Week 24 [Baseline to Week 24]

      3 Expert Graders evaluated periorbital wrinkles on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.

    12. Surface Roughness - Change From Baseline to Week 1 [Baseline to Week 1]

      3 Expert Graders evaluated surface roughness on a 0-9 scale, where 0 = perfectly smooth to 9 = severe roughness (visible and tactile). The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.

    13. Surface Roughness - Change From Baseline to Week 4 [Baseline to Week 4]

      3 Expert Graders evaluated surface roughness on a 0-9 scale, where 0 = perfectly smooth to 9 = severe roughness (visible and tactile). The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.

    14. Surface Roughness - Change From Baseline to Week 12 [Baseline to Week 12]

      3 Expert Graders evaluated surface roughness on a 0-9 scale, where 0 = perfectly smooth to 9 = severe roughness (visible and tactile). The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.

    15. Surface Roughness - Change From Baseline to Week 24 [Week 24]

      3 Expert Graders evaluated surface roughness on a 0-9 scale, where 0 = perfectly smooth to 9 = severe roughness (visible and tactile). The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.

    16. Uneven Skin Tone - Change From Baseline to Week 1 [Baseline to Week 1]

      3 Expert Graders evaluated uneven skin tone on a 0-9 scale, where 0 = perfectly uniform/even skin tone to 9 = pronounced/severe uneven skin tone. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.

    17. Uneven Skin Tone - Change From Baseline to Week 4 [Baseline to Week 4]

      3 Expert Graders evaluated uneven skin tone on a 0-9 scale, where 0 = perfectly uniform/even skin tone to 9 = pronounced/severe uneven skin tone. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.

    18. Uneven Skin Tone - Change From Baseline to Week 12 [Baseline to Week 12]

      3 Expert Graders evaluated uneven skin tone on a 0-9 scale, where 0 = perfectly uniform/even skin tone to 9 = pronounced/severe uneven skin tone. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.

    19. Uneven Skin Tone - Change From Baseline to Week 24 [Baseline to Week 24]

      3 Expert Graders evaluated uneven skin tone on a 0-9 scale, where 0 = perfectly uniform/even skin tone to 9 = pronounced/severe uneven skin tone. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.

    20. Mottled Hyperpigmentation - Change From Baseline to Week 1 [Baseline to Week 1]

      3 Expert Graders evaluated mottled hyperpigmentation on a 0-9 scale, where 0 = none (perfectly even tone) to 9 = severe mottled hyperpigmentation. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.

    21. Mottled Hyperpigmentation - Change From Baseline to Week 4 [Baseline to Week 4]

      3 Expert Graders evaluated mottled hyperpigmentation on a 0-9 scale, where 0 = none (perfectly even tone) to 9 = severe mottled hyperpigmentation. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.

    22. Mottled Hyperpigmentation - Change From Baseline to Week 12 [Baseline to Week 12]

      3 Expert Graders evaluated mottled hyperpigmentation on a 0-9 scale, where 0 = none (perfectly even tone) to 9 = severe mottled hyperpigmentation. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.

    23. Mottled Hyperpigmentation - Change From Baseline to Week 24 [Baseline to Week 24]

      3 Expert Graders evaluated mottled hyperpigmentation on a 0-9 scale, where 0 = none (perfectly even tone) to 9 = severe mottled hyperpigmentation. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.

    24. Sallowness/Yellowing - Change From Baseline to Week 1 [Baseline to Week 1]

      3 Expert Graders evaluated sallowness/yellowing on a 0-9 scale, where 0 = none to 9 = severe. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.

    25. Sallowness/Yellowing - Change From Baseline to Week 4 [Baseline to Week 4]

      3 Expert Graders evaluated sallowness/yellowing on a 0-9 scale, where 0 = none to 9 = severe. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.

    26. Sallowness/Yellowing - Change From Baseline to Week 12 [Baseline to Week 12]

      3 Expert Graders evaluated sallowness/yellowing on a 0-9 scale, where 0 = none to 9 = severe. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.

    27. Sallowness/Yellowing - Change From Baseline to Week 24 [Baseline to Week 24]

      3 Expert Graders evaluated sallowness/yellowing on a 0-9 scale, where 0 = none to 9 = severe. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.

    28. Lack of Radiance - Change From Baseline to Week 1 [Baseline to Week 1]

      3 Expert Graders evaluated lack of radiance on a 0-9 scale, where 0 = none (extremely radiant) to 9 = severe dullness/matte appearance. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.

    29. Lack of Radiance - Change From Baseline to Week 4 [Baseline to Week 4]

      3 Expert Graders evaluated lack of radiance on a 0-9 scale, where 0 = none (extremely radiant) to 9 = severe dullness/matte appearance. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.

    30. Lack of Radiance - Change From Baseline to Week 12 [Baseline to Week 12]

      3 Expert Graders evaluated lack of radiance on a 0-9 scale, where 0 = none (extremely radiant) to 9 = severe dullness/matte appearance. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.

    31. Lack of Radiance - Change From Baseline to Week 24 [Baseline to Week 24]

      3 Expert Graders evaluated lack of radiance on a 0-9 scale, where 0 = none (extremely radiant) to 9 = severe dullness/matte appearance. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    35 Years to 70 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Has mild to moderate brown spots

    • Has moderate to severe facial wrinkling

    • Able to read, write, speak, and understand English

    • In general good health

    • If capable of having a child: must agree to practice a medically acceptable form of birth control.

    • Intends to complete the study and willing to follow all study directions.

    Exclusion Criteria:
    • Allergies/sensitivity to skincare products or the test product ingredients

    • Has a light or photosensitivity disorder or another medical condition that could increase risk to the subject or confuse the study results.

    • Is taking medication that may cause skin sensitivity to light

    • Has been using a product or medication that the study investigator determines will increase health risk to the subject or confuse the study results

    • Has a facial skin condition (e.g. rosacea, acne, eczema, etc.) that could increase health risk to the subject or confuse the study results.

    • Has skin cancer or a history of skin cancer.

    • Has an immune deficiency disorder, active hepatitis, or an autoimmune disease.

    • Has an uncontrolled metabolic condition (e.g. diabetes, hypertension)

    • Is pregnant, nursing, or planning to become pregnant.

    • Plans to start or change a hormone replacement therapy during the study.

    • Has participated in another study in the past 30 days or plans to during the study.

    • Is an employee or relative of the Study Site, Investigator, or Sponsor.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 KGL Skin Study Center, LLC Broomall Pennsylvania United States 19008

    Sponsors and Collaborators

    • Johnson & Johnson Consumer Inc. (J&JCI)

    Investigators

    • Principal Investigator: Stuart Lessin, M.D., KGL Skin Study Center, LLC

    Study Documents (Full-Text)

    More Information

    Publications

    Responsible Party:
    Johnson & Johnson Consumer Inc. (J&JCI)
    ClinicalTrials.gov Identifier:
    NCT03312543
    Other Study ID Numbers:
    • CO-170511132943-SACT
    First Posted:
    Oct 17, 2017
    Last Update Posted:
    Mar 5, 2019
    Last Verified:
    Feb 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Johnson & Johnson Consumer Inc. (J&JCI)

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail At Visit 1 (Screening), participants were enrolled in the study and randomized to the active cell or the sham cell (stratified by skin type). All participants received the same facial cleanser and moisturizer with SPF to use between Visit 1 and Visit 2, and then received the assigned test product (Active Mask or Sham Mask) at Visit 2 (Baseline).
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Period Title: Before Treatment (Screening to Baseline)
    STARTED 61 63
    COMPLETED 60 59
    NOT COMPLETED 1 4
    Period Title: Before Treatment (Screening to Baseline)
    STARTED 60 59
    COMPLETED 56 54
    NOT COMPLETED 4 5
    Period Title: Before Treatment (Screening to Baseline)
    STARTED 56 54
    COMPLETED 55 52
    NOT COMPLETED 1 2

    Baseline Characteristics

    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask Total
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. Total of all reporting groups
    Overall Participants 61 63 124
    Age (Years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [Years]
    56.3
    (8.02)
    56.6
    (7.34)
    56.5
    (7.65)
    Sex: Female, Male (Count of Participants)
    Female
    61
    100%
    63
    100%
    124
    100%
    Male
    0
    0%
    0
    0%
    0
    0%
    Ethnicity (NIH/OMB) (Count of Participants)
    Hispanic or Latino
    1
    1.6%
    1
    1.6%
    2
    1.6%
    Not Hispanic or Latino
    60
    98.4%
    62
    98.4%
    122
    98.4%
    Unknown or Not Reported
    0
    0%
    0
    0%
    0
    0%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    0
    0%
    0
    0%
    0
    0%
    Asian
    0
    0%
    0
    0%
    0
    0%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    0
    0%
    0
    0%
    Black or African American
    15
    24.6%
    18
    28.6%
    33
    26.6%
    White
    45
    73.8%
    45
    71.4%
    90
    72.6%
    More than one race
    0
    0%
    0
    0%
    0
    0%
    Unknown or Not Reported
    1
    1.6%
    0
    0%
    1
    0.8%
    Fitzpatrick Skin Type (Count of Participants)
    I
    11
    18%
    11
    17.5%
    22
    17.7%
    II
    11
    18%
    11
    17.5%
    22
    17.7%
    III
    9
    14.8%
    11
    17.5%
    20
    16.1%
    IV
    10
    16.4%
    11
    17.5%
    21
    16.9%
    V
    10
    16.4%
    9
    14.3%
    19
    15.3%
    VI
    10
    16.4%
    10
    15.9%
    20
    16.1%
    Skin Oiliness Level (Count of Participants)
    Oily
    2
    3.3%
    4
    6.3%
    6
    4.8%
    Dry
    9
    14.8%
    13
    20.6%
    22
    17.7%
    Normal
    23
    37.7%
    17
    27%
    40
    32.3%
    Combination
    27
    44.3%
    29
    46%
    56
    45.2%

    Outcome Measures

    1. Primary Outcome
    Title Global Wrinkling - Change From Baseline to Week 12, Averaged Expert Grader Scores
    Description 3 Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 12

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. Missing values were imputed by carrying forward the last observed post-baseline score. 5 subjects withdrew prior to baseline and there was no post-baseline data to carry forward for an additional 3 subjects.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 59 57
    Mean (Standard Deviation) [Units on a scale]
    0.18
    (0.328)
    0.30
    (0.341)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Sham Cell: Sham Mask
    Comments
    Type of Statistical Test Superiority
    Comments Superiority to baseline concluded if the lower bound of the 95% confidence interval for the mean difference is above 0.5.
    Statistical Test of Hypothesis p-Value <0.001
    Comments
    Method t-test, 2 sided
    Comments
    Method of Estimation Estimation Parameter Mean Difference (Net)
    Estimated Value 0.18
    Confidence Interval (2-Sided) 95%
    0.09 to 0.26
    Parameter Dispersion Type: Standard Deviation
    Value: 0.328
    Estimation Comments
    Statistical Analysis 2
    Statistical Analysis Overview Comparison Group Selection Active Cell: Active Mask
    Comments
    Type of Statistical Test Superiority
    Comments Superiority to baseline concluded if the lower bound of the 95% confidence interval for the mean difference is above 0.5.
    Statistical Test of Hypothesis p-Value <0.001
    Comments
    Method t-test, 2 sided
    Comments
    Method of Estimation Estimation Parameter Mean Difference (Net)
    Estimated Value 0.30
    Confidence Interval (2-Sided) 95%
    0.21 to 0.39
    Parameter Dispersion Type: Standard Deviation
    Value: 0.341
    Estimation Comments
    Statistical Analysis 3
    Statistical Analysis Overview Comparison Group Selection Sham Cell: Sham Mask, Active Cell: Active Mask
    Comments
    Type of Statistical Test Other
    Comments The null hypothesis was that the change from baseline to Week 12 was equal for the active cell and the sham cell. The alternative hypothesis was that the mean change from Baseline was not equal between the two cells.
    Statistical Test of Hypothesis p-Value 0.025
    Comments
    Method ANCOVA
    Comments With treatment and skin type group as factors and the corresponding averaged baseline score as a covariate.
    Method of Estimation Estimation Parameter Mean Difference (Net)
    Estimated Value 0.14
    Confidence Interval (2-Sided) 95%
    0.02 to 0.25
    Parameter Dispersion Type: Standard Error of the Mean
    Value: 0.060
    Estimation Comments
    2. Primary Outcome
    Title Global Wrinkling - Change From Baseline to Week 12, Individual Expert Grader Scores - Expert Grader 1
    Description Each Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement. Scores for Expert Grader 1 were calculated individually.
    Time Frame Baseline to Week 12

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. Missing values were imputed by carrying forward the last observed post-baseline score. 5 subjects withdrew prior to baseline and there was no post-baseline data to carry forward for an additional 3 subjects.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 59 57
    Mean (Standard Deviation) [Units on a scale.]
    0.20
    (0.349)
    0.22
    (0.328)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Sham Cell: Sham Mask
    Comments
    Type of Statistical Test Superiority
    Comments Superiority to baseline concluded if the lower bound of the 95% confidence interval for the mean difference is above 0.5.
    Statistical Test of Hypothesis p-Value <0.001
    Comments
    Method t-test, 2 sided
    Comments
    Method of Estimation Estimation Parameter Mean Difference (Net)
    Estimated Value 0.20
    Confidence Interval (2-Sided) 95%
    0.11 to 0.29
    Parameter Dispersion Type: Standard Deviation
    Value: 0.349
    Estimation Comments
    Statistical Analysis 2
    Statistical Analysis Overview Comparison Group Selection Active Cell: Active Mask
    Comments
    Type of Statistical Test Superiority
    Comments Superiority to baseline concluded if the lower bound of the 95% confidence interval for the mean difference is above 0.5.
    Statistical Test of Hypothesis p-Value <0.001
    Comments
    Method t-test, 2 sided
    Comments
    Method of Estimation Estimation Parameter Mean Difference (Net)
    Estimated Value 0.22
    Confidence Interval (2-Sided) 95%
    0.13 to 0.31
    Parameter Dispersion Type: Standard Deviation
    Value: 0.328
    Estimation Comments
    Statistical Analysis 3
    Statistical Analysis Overview Comparison Group Selection Sham Cell: Sham Mask, Active Cell: Active Mask
    Comments
    Type of Statistical Test Equivalence
    Comments The null hypothesis was that the change from baseline to Week 12 was equal for the active cell and the sham cell. The alternative hypothesis was that the mean change from Baseline was not equal between the two cells.
    Statistical Test of Hypothesis p-Value 0.540
    Comments
    Method ANCOVA
    Comments With treatment and skin type group as factors and the corresponding averaged baseline score as a covariate.
    Method of Estimation Estimation Parameter Mean Difference (Net)
    Estimated Value 0.04
    Confidence Interval (2-Sided) 95%
    -0.09 to 0.16
    Parameter Dispersion Type: Standard Error of the Mean
    Value: 0.062
    Estimation Comments
    3. Primary Outcome
    Title Global Wrinkling - Change From Baseline to Week 12, Individual Expert Grader Scores - Expert Grader 2
    Description Each Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement. Scores for Expert Grader 2 were calculated individually.
    Time Frame Baseline to Week 12

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. Missing values were imputed by carrying forward the last observed post-baseline score. 5 subjects withdrew prior to baseline and there was no post-baseline data to carry forward for an additional 3 subjects.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 59 57
    Mean (Standard Deviation) [Units on a scale.]
    -0.03
    (0.532)
    0.21
    (0.500)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Sham Cell: Sham Mask
    Comments
    Type of Statistical Test Superiority
    Comments Superiority to baseline concluded if the lower bound of the 95% confidence interval for the mean difference is above 0.5.
    Statistical Test of Hypothesis p-Value 0.627
    Comments
    Method t-test, 2 sided
    Comments
    Method of Estimation Estimation Parameter Mean Difference (Net)
    Estimated Value -0.03
    Confidence Interval (2-Sided) 95%
    -0.17 to 0.10
    Parameter Dispersion Type: Standard Deviation
    Value: 0.532
    Estimation Comments
    Statistical Analysis 2
    Statistical Analysis Overview Comparison Group Selection Active Cell: Active Mask
    Comments
    Type of Statistical Test Superiority
    Comments Superiority to baseline concluded if the lower bound of the 95% confidence interval for the mean difference is above 0.5.
    Statistical Test of Hypothesis p-Value 0.002
    Comments
    Method t-test, 2 sided
    Comments
    Method of Estimation Estimation Parameter Mean Difference (Net)
    Estimated Value 0.21
    Confidence Interval (2-Sided) 95%
    0.08 to 0.34
    Parameter Dispersion Type: Standard Deviation
    Value: 0.500
    Estimation Comments
    Statistical Analysis 3
    Statistical Analysis Overview Comparison Group Selection Sham Cell: Sham Mask, Active Cell: Active Mask
    Comments
    Type of Statistical Test Equivalence
    Comments The null hypothesis was that the change from baseline to Week 12 was equal for the active cell and the sham cell. The alternative hypothesis was that the mean change from Baseline was not equal between the two cells.
    Statistical Test of Hypothesis p-Value 0.009
    Comments
    Method ANCOVA
    Comments With treatment and skin type group as factors and the corresponding averaged baseline score as a covariate.
    Method of Estimation Estimation Parameter Mean Difference (Net)
    Estimated Value 0.24
    Confidence Interval (2-Sided) 95%
    0.06 to 0.42
    Parameter Dispersion Type: Standard Error of the Mean
    Value: 0.092
    Estimation Comments
    4. Primary Outcome
    Title Global Wrinkling - Change From Baseline to Week 12, Individual Expert Grader Scores - Expert Grader 3
    Description Each Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement. Scores for Expert Grader 3 were calculated individually.
    Time Frame Baseline to Week 12

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. Missing values were imputed by carrying forward the last observed post-baseline score. 5 subjects withdrew prior to baseline and there was no post-baseline data to carry forward for an additional 3 subjects.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 59 57
    Mean (Standard Deviation) [Units on a scale.]
    0.36
    (0.465)
    0.47
    (0.578)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Sham Cell: Sham Mask
    Comments
    Type of Statistical Test Superiority
    Comments Superiority to baseline concluded if the lower bound of the 95% confidence interval for the mean difference is above 0.5.
    Statistical Test of Hypothesis p-Value <0.001
    Comments
    Method t-test, 2 sided
    Comments
    Method of Estimation Estimation Parameter Mean Difference (Net)
    Estimated Value 0.36
    Confidence Interval (2-Sided) 95%
    0.23 to 0.48
    Parameter Dispersion Type: Standard Deviation
    Value: 0.465
    Estimation Comments
    Statistical Analysis 2
    Statistical Analysis Overview Comparison Group Selection Active Cell: Active Mask
    Comments
    Type of Statistical Test Superiority
    Comments Superiority to baseline concluded if the lower bound of the 95% confidence interval for the mean difference is above 0.5.
    Statistical Test of Hypothesis p-Value <0.001
    Comments
    Method t-test, 2 sided
    Comments
    Method of Estimation Estimation Parameter Mean Difference (Net)
    Estimated Value 0.47
    Confidence Interval (2-Sided) 95%
    0.32 to 0.63
    Parameter Dispersion Type: Standard Deviation
    Value: 0.578
    Estimation Comments
    Statistical Analysis 3
    Statistical Analysis Overview Comparison Group Selection Sham Cell: Sham Mask, Active Cell: Active Mask
    Comments
    Type of Statistical Test Equivalence
    Comments The null hypothesis was that the change from baseline to Week 12 was equal for the active cell and the sham cell. The alternative hypothesis was that the mean change from Baseline was not equal between the two cells.
    Statistical Test of Hypothesis p-Value 0.224
    Comments
    Method ANCOVA
    Comments With treatment and skin type group as factors and the corresponding averaged baseline score as a covariate.
    Method of Estimation Estimation Parameter Mean Difference (Net)
    Estimated Value 0.11
    Confidence Interval (2-Sided) 95%
    -0.07 to 0.30
    Parameter Dispersion Type: Standard Error of the Mean
    Value: 0.094
    Estimation Comments
    5. Secondary Outcome
    Title Global Wrinkling - Change From Baseline to Week 1
    Description 3 Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 1

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 59 57
    Mean (Standard Deviation) [Units on a scale]
    0.03
    (0.158)
    0.04
    (0.157)
    6. Secondary Outcome
    Title Global Wrinkling - Change From Baseline to Week 4
    Description 3 Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 4

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 56
    Mean (Standard Deviation) [Units on a scale]
    0.09
    (0.208)
    0.09
    (0.198)
    7. Secondary Outcome
    Title Global Wrinkling - Change From Baseline to Week 24
    Description 3 Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 24

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 55 52
    Mean (Standard Deviation) [Units on a scale]
    0.24
    (0.410)
    0.30
    (0.378)
    8. Secondary Outcome
    Title Fine Lines - Change From Baseline to Week 1
    Description 3 Expert Graders evaluated fine lines on a 1-9 scale, where 1 = mildest fine lines to 9 = most severe fine lines. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.
    Time Frame 1 week

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 59 57
    Mean (Standard Deviation) [Units on a scale]
    0.01
    (0.132)
    0.05
    (0.160)
    9. Secondary Outcome
    Title Fine Lines - Change From Baseline to Week 4
    Description 3 Expert Graders evaluated fine lines on a 1-9 scale, where 1 = mildest fine lines to 9 = most severe fine lines. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 4

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 56
    Mean (Standard Deviation) [Units on a Scale]
    0.08
    (0.196)
    0.13
    (0.205)
    10. Secondary Outcome
    Title Fine Lines - Change From Baseline to Week 12
    Description 3 Expert Graders evaluated fine lines on a 1-9 scale, where 1 = mildest fine lines to 9 = most severe fine lines. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 12

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 54
    Mean (Standard Deviation) [Units on a Scale]
    0.23
    (0.309)
    0.32
    (0.358)
    11. Secondary Outcome
    Title Fine Lines - Change From Baseline to Week 24
    Description 3 Expert Graders evaluated fine lines on a 1-9 scale, where 1 = mildest fine lines to 9 = most severe fine lines. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 24

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 55 52
    Mean (Standard Deviation) [Units on a Scale]
    0.28
    (0.358)
    0.29
    (0.349)
    12. Secondary Outcome
    Title Periorbital Wrinkles - Change From Baseline to Week 1
    Description 3 Expert Graders evaluated periorbital wrinkles on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 1

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 59 57
    Mean (Standard Deviation) [Units on a Scale]
    0.00
    (0.176)
    0.01
    (0.172)
    13. Secondary Outcome
    Title Periorbital Wrinkles - Change From Baseline to Week 4
    Description 3 Expert Graders evaluated periorbital wrinkles on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 4

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 56
    Mean (Standard Deviation) [Units on a Scale]
    0.10
    (0.269)
    0.10
    (0.246)
    14. Secondary Outcome
    Title Periorbital Wrinkles - Change From Baseline to Week 12
    Description 3 Expert Graders evaluated periorbital wrinkles on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 12

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 64
    Mean (Standard Deviation) [Units on a Scale]
    0.15
    (0.355)
    0.30
    (0.366)
    15. Secondary Outcome
    Title Periorbital Wrinkles - Change From Baseline to Week 24
    Description 3 Expert Graders evaluated periorbital wrinkles on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 24

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 55 52
    Mean (Standard Deviation) [Units on a Scale]
    0.22
    (0.399)
    0.29
    (0.401)
    16. Secondary Outcome
    Title Surface Roughness - Change From Baseline to Week 1
    Description 3 Expert Graders evaluated surface roughness on a 0-9 scale, where 0 = perfectly smooth to 9 = severe roughness (visible and tactile). The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 1

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 59 57
    Mean (Standard Deviation) [Units on a Scale]
    0.35
    (0.396)
    0.38
    (0.386)
    17. Secondary Outcome
    Title Surface Roughness - Change From Baseline to Week 4
    Description 3 Expert Graders evaluated surface roughness on a 0-9 scale, where 0 = perfectly smooth to 9 = severe roughness (visible and tactile). The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 4

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 56
    Mean (Standard Deviation) [Units on a Scale]
    0.79
    (0.438)
    0.76
    (0.520)
    18. Secondary Outcome
    Title Surface Roughness - Change From Baseline to Week 12
    Description 3 Expert Graders evaluated surface roughness on a 0-9 scale, where 0 = perfectly smooth to 9 = severe roughness (visible and tactile). The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 12

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 54
    Mean (Standard Deviation) [Units on a Scale]
    0.94
    (0.449)
    0.89
    (0.576)
    19. Secondary Outcome
    Title Surface Roughness - Change From Baseline to Week 24
    Description 3 Expert Graders evaluated surface roughness on a 0-9 scale, where 0 = perfectly smooth to 9 = severe roughness (visible and tactile). The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.
    Time Frame Week 24

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 55 52
    Mean (Standard Deviation) [Units on a Scale]
    1.12
    (0.549)
    0.95
    (0.686)
    20. Secondary Outcome
    Title Uneven Skin Tone - Change From Baseline to Week 1
    Description 3 Expert Graders evaluated uneven skin tone on a 0-9 scale, where 0 = perfectly uniform/even skin tone to 9 = pronounced/severe uneven skin tone. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 1

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 59 57
    Mean (Standard Deviation) [Units on a Scale]
    0.04
    (0.176)
    0.06
    (0.119)
    21. Secondary Outcome
    Title Uneven Skin Tone - Change From Baseline to Week 4
    Description 3 Expert Graders evaluated uneven skin tone on a 0-9 scale, where 0 = perfectly uniform/even skin tone to 9 = pronounced/severe uneven skin tone. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 4

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 56
    Mean (Standard Deviation) [Units on a Scale]
    0.18
    (0.282)
    0.23
    (0.287)
    22. Secondary Outcome
    Title Uneven Skin Tone - Change From Baseline to Week 12
    Description 3 Expert Graders evaluated uneven skin tone on a 0-9 scale, where 0 = perfectly uniform/even skin tone to 9 = pronounced/severe uneven skin tone. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 12

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 54
    Mean (Standard Deviation) [Units on a Scale]
    0.36
    (0.388)
    0.49
    (0.487)
    23. Secondary Outcome
    Title Uneven Skin Tone - Change From Baseline to Week 24
    Description 3 Expert Graders evaluated uneven skin tone on a 0-9 scale, where 0 = perfectly uniform/even skin tone to 9 = pronounced/severe uneven skin tone. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 24

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 55 52
    Mean (Standard Deviation) [Units on a Scale]
    0.44
    (0.378)
    0.52
    (0.499)
    24. Secondary Outcome
    Title Mottled Hyperpigmentation - Change From Baseline to Week 1
    Description 3 Expert Graders evaluated mottled hyperpigmentation on a 0-9 scale, where 0 = none (perfectly even tone) to 9 = severe mottled hyperpigmentation. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 1

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 59 57
    Mean (Standard Deviation) [Units on a Scale]
    -0.01
    (0.166)
    -0.02
    (0.174)
    25. Secondary Outcome
    Title Mottled Hyperpigmentation - Change From Baseline to Week 4
    Description 3 Expert Graders evaluated mottled hyperpigmentation on a 0-9 scale, where 0 = none (perfectly even tone) to 9 = severe mottled hyperpigmentation. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 4

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 56
    Mean (Standard Deviation) [Units on a Scale]
    0.10
    (0.313)
    0.15
    (0.288)
    26. Secondary Outcome
    Title Mottled Hyperpigmentation - Change From Baseline to Week 12
    Description 3 Expert Graders evaluated mottled hyperpigmentation on a 0-9 scale, where 0 = none (perfectly even tone) to 9 = severe mottled hyperpigmentation. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 12

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 54
    Mean (Standard Deviation) [Units on a Scale]
    0.22
    (0.456)
    0.39
    (0.392)
    27. Secondary Outcome
    Title Mottled Hyperpigmentation - Change From Baseline to Week 24
    Description 3 Expert Graders evaluated mottled hyperpigmentation on a 0-9 scale, where 0 = none (perfectly even tone) to 9 = severe mottled hyperpigmentation. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 24

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 55 52
    Mean (Standard Deviation) [Units on a Scale]
    0.25
    (0.467)
    0.31
    (0.401)
    28. Secondary Outcome
    Title Sallowness/Yellowing - Change From Baseline to Week 1
    Description 3 Expert Graders evaluated sallowness/yellowing on a 0-9 scale, where 0 = none to 9 = severe. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 1

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 59 57
    Mean (Standard Deviation) [Units on a Scale]
    -0.01
    (0.276)
    0.01
    (0.179)
    29. Secondary Outcome
    Title Sallowness/Yellowing - Change From Baseline to Week 4
    Description 3 Expert Graders evaluated sallowness/yellowing on a 0-9 scale, where 0 = none to 9 = severe. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 4

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 56
    Mean (Standard Deviation) [Units on a Scale]
    0.12
    (0.247)
    0.12
    (0.354)
    30. Secondary Outcome
    Title Sallowness/Yellowing - Change From Baseline to Week 12
    Description 3 Expert Graders evaluated sallowness/yellowing on a 0-9 scale, where 0 = none to 9 = severe. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 12

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 54
    Mean (Standard Deviation) [Units on a Scale]
    0.23
    (0.390)
    0.33
    (0.496)
    31. Secondary Outcome
    Title Sallowness/Yellowing - Change From Baseline to Week 24
    Description 3 Expert Graders evaluated sallowness/yellowing on a 0-9 scale, where 0 = none to 9 = severe. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 24

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 55 52
    Mean (Standard Deviation) [Units on a Scale]
    0.29
    (0.445)
    0.32
    (0.504)
    32. Secondary Outcome
    Title Lack of Radiance - Change From Baseline to Week 1
    Description 3 Expert Graders evaluated lack of radiance on a 0-9 scale, where 0 = none (extremely radiant) to 9 = severe dullness/matte appearance. The 3 Expert Grader scores were averaged for Baseline and for Week 1. Change from baseline was calculated as Baseline mean minus Week 1 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 1

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 59 57
    Mean (Standard Deviation) [Units on a Scale]
    0.07
    (0.219)
    0.13
    (0.258)
    33. Secondary Outcome
    Title Lack of Radiance - Change From Baseline to Week 4
    Description 3 Expert Graders evaluated lack of radiance on a 0-9 scale, where 0 = none (extremely radiant) to 9 = severe dullness/matte appearance. The 3 Expert Grader scores were averaged for Baseline and for Week 4. Change from baseline was calculated as Baseline mean minus Week 4 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 4

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 56
    Mean (Standard Deviation) [Units on a Scale]
    0.28
    (0.357)
    0.37
    (0.401)
    34. Secondary Outcome
    Title Lack of Radiance - Change From Baseline to Week 12
    Description 3 Expert Graders evaluated lack of radiance on a 0-9 scale, where 0 = none (extremely radiant) to 9 = severe dullness/matte appearance. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 12

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 56 54
    Mean (Standard Deviation) [Units on a Scale]
    0.41
    (0.412)
    0.55
    (0.493)
    35. Secondary Outcome
    Title Lack of Radiance - Change From Baseline to Week 24
    Description 3 Expert Graders evaluated lack of radiance on a 0-9 scale, where 0 = none (extremely radiant) to 9 = severe dullness/matte appearance. The 3 Expert Grader scores were averaged for Baseline and for Week 24. Change from baseline was calculated as Baseline mean minus Week 24 mean so a positive score indicates improvement.
    Time Frame Baseline to Week 24

    Outcome Measure Data

    Analysis Population Description
    Intent-to-treat population was used, including all subjects with data for this time point. The number analyzed may be less than the total due to subject withdrawal prior to this time point or missed visits/evaluations.
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    Measure Participants 55 52
    Mean (Standard Deviation) [Units on a Scale]
    0.54
    (0.454)
    0.59
    (0.517)

    Adverse Events

    Time Frame Adverse events (AEs) were collected from time of informed consent through subject's last study procedure (Week 24 unless terminated early). Serious adverse events (SAE) reported to the site were also reportable within 30 days of last procedure/visit and longer if considered study-related; there was no specific cut-off date for this reporting, but AEs/SAEs are shown in this posting for a collection period of approximately 6 months from last subject's visit (the time of this posting).
    Adverse Event Reporting Description The Investigator or a designee interviewed subjects for changes in health/medication at each visit, documenting any reported adverse events. The analysis population is all randomized subjects who used the investigational device (i.e. the subjects enrolled in the treatment period).
    Arm/Group Title Sham Cell: Sham Mask Active Cell: Active Mask
    Arm/Group Description A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the sham light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued. A facial cleanser was used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF was applied full-face. For the first 12 weeks of the study, the active light therapy mask was used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage was discontinued.
    All Cause Mortality
    Sham Cell: Sham Mask Active Cell: Active Mask
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/60 (0%) 1/59 (1.7%)
    Serious Adverse Events
    Sham Cell: Sham Mask Active Cell: Active Mask
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/60 (0%) 1/59 (1.7%)
    General disorders
    Sudden Death 0/60 (0%) 0 1/59 (1.7%) 1
    Other (Not Including Serious) Adverse Events
    Sham Cell: Sham Mask Active Cell: Active Mask
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 4/60 (6.7%) 5/59 (8.5%)
    Infections and infestations
    Upper Respiratory Tract Infection 1/60 (1.7%) 1 5/59 (8.5%) 5
    Oral Herpes 3/60 (5%) 3 0/59 (0%) 0

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    PI must provide Sponsor 60 days to review any publication (unless expedited review requested); if it includes Sponsor's confidential info, written Sponsor approval is required. Sponsor may require another 60 days' delay to file a patent application.

    Results Point of Contact

    Name/Title Sidney Hornby
    Organization Johnson & Johnson Consumer Inc.
    Phone 908-874-2756
    Email SHornby@its.jnj.com
    Responsible Party:
    Johnson & Johnson Consumer Inc. (J&JCI)
    ClinicalTrials.gov Identifier:
    NCT03312543
    Other Study ID Numbers:
    • CO-170511132943-SACT
    First Posted:
    Oct 17, 2017
    Last Update Posted:
    Mar 5, 2019
    Last Verified:
    Feb 1, 2019